Hangchuan Shi
- Cancer Research top 10%
- MicroRNA in disease regulation 2
-
- Renal and related cancers 4
- Phosphodiesterase function and regulation 4
- Epigenetics and DNA Methylation 2
-
- Renal cell carcinoma treatment 2
-
- Smoking Behavior and Cessation 4
-
- Bladder and Urothelial Cancer Treatments 2
-
- Nutritional Studies and Diet 2
- Co-authors
- Hongmei YangXiaoping ZhangWeiwei HanAnming RuanYan ZhaoDongmei LiXuanyu ChenYan Chen
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Circulation (1 paper)Circulation Research (3 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Hangchuan Shi
23 papers receiving 472 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 213
- Molecular Biology 299
- Pulmonary and Respiratory Medicine 118
- Cardiology and Cardiovascular Medicine 48
- Oncology 54
Countries citing papers authored by Hangchuan Shi
This map shows the geographic impact of Hangchuan Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangchuan Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangchuan Shi more than expected).
Fields of papers citing papers by Hangchuan Shi
This network shows the impact of papers produced by Hangchuan Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangchuan Shi. The network helps show where Hangchuan Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hangchuan Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 38 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 7 | |
| 8 | 2021 | 37 | |
| 9 | 2021 | 21 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 12 | |
| 12 | 2020 | 4 | |
| 13 | 2020 | 9 | |
| 14 | 2019 | 22 | |
| 15 | 2018 | 15 | |
| 16 | 2018 | 45 | |
| 17 | 2017 | 13 | |
| 18 | 2016 | 45 | |
| 19 | 2014 | 127 | |
| 20 | 2012 | 4 |
About Hangchuan Shi
Hangchuan Shi is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Cancer Research, having authored 24 papers that have together received 477 indexed citations. Recurring topics across this work include Renal and related cancers (4 papers), Smoking Behavior and Cessation (4 papers), Phosphodiesterase function and regulation (4 papers), Renal cell carcinoma treatment (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Epigenetics and DNA Methylation (2 papers), Nutritional Studies and Diet (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (213 citations), Molecular Biology (299 citations) and Pulmonary and Respiratory Medicine (118 citations). Hangchuan Shi has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Hongmei Yang, Xiaoping Zhang, Weiwei Han, Anming Ruan, Yan Zhao, Dongmei Li, Xuanyu Chen, Yan Chen, Rong Wang and Xing Lü. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.